{"id":77829,"date":"2021-08-06T03:00:12","date_gmt":"2021-08-06T01:00:12","guid":{"rendered":"https:\/\/www.cde.ual.es\/?p=77829"},"modified":"2021-08-05T13:38:23","modified_gmt":"2021-08-05T11:38:23","slug":"commission-approves-new-contract-for-a-potential-covid-19-vaccine-with-novavax","status":"publish","type":"post","link":"https:\/\/www.cde.ual.es\/en\/commission-approves-new-contract-for-a-potential-covid-19-vaccine-with-novavax\/","title":{"rendered":"Commission approves new contract for a potential COVID-19 vaccine with Novavax"},"content":{"rendered":"<p><strong>The European Commission has approved its seventh Advanced Purchase Agreement (APA) with a pharmaceutical company to ensure access to a potential <a href=\"https:\/\/www.cde.ual.es\/en\/covid-19-vaccination-in-europe\/\">vaccine<\/a> against<a href=\"https:\/\/www.cde.ual.es\/en\/coronavirus-present-situation-in-europe\/\"> COVID-19<\/a> in Q4 of 2021 and in 2022.<\/strong><\/p>\n<p><a href=\"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2021\/02\/vacuna-scaled.jpg\"><img decoding=\"async\" class=\" wp-image-61133 aligncenter\" src=\"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2021\/02\/vacuna-scaled.jpg\" alt=\"Situaci\u00f3n Vacunaci\u00f3n COVID-19 en Espa\u00f1a y Europa\" width=\"591\" height=\"394\" srcset=\"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2021\/02\/vacuna-scaled.jpg 2560w, https:\/\/www.cde.ual.es\/wp-content\/uploads\/2021\/02\/vacuna-300x200.jpg 300w, https:\/\/www.cde.ual.es\/wp-content\/uploads\/2021\/02\/vacuna-1024x683.jpg 1024w, https:\/\/www.cde.ual.es\/wp-content\/uploads\/2021\/02\/vacuna-768x512.jpg 768w, https:\/\/www.cde.ual.es\/wp-content\/uploads\/2021\/02\/vacuna-1536x1024.jpg 1536w, https:\/\/www.cde.ual.es\/wp-content\/uploads\/2021\/02\/vacuna-2048x1365.jpg 2048w\" sizes=\"(max-width: 591px) 100vw, 591px\" \/><\/a><\/p>\n<p>Under this contract, Member States will be able to purchase up to 100 million doses of the Novavax vaccine, with an option for 100 million additional doses over the course of 2021, 2022, and 2023, once reviewed and approved by EMA as safe and effective. Member States will also be able to donate vaccines to lower and middle-income countries or to re-direct them to other European countries.<\/p>\n<p>This contract complements \u00a0an already broad portfolio of vaccines to be produced in Europe, including the contracts with <a href=\"https:\/\/ec.europa.eu\/commission\/presscorner\/detail\/en\/ip_20_1524\">AstraZeneca<\/a>,\u00a0<a href=\"https:\/\/ec.europa.eu\/commission\/presscorner\/detail\/en\/ip_20_1680\">Sanofi-GSK<\/a>,\u00a0<a href=\"https:\/\/ec.europa.eu\/commission\/presscorner\/detail\/en\/ip_20_1829\">Janssen Pharmaceutica NV<\/a>,\u00a0<a href=\"https:\/\/ec.europa.eu\/commission\/presscorner\/detail\/en\/ip_20_2081\">BioNtech-Pfize<\/a>r,\u00a0<a href=\"https:\/\/ec.europa.eu\/commission\/presscorner\/detail\/en\/ip_20_2136\">CureVac<\/a>,\u00a0<a href=\"https:\/\/ec.europa.eu\/commission\/presscorner\/detail\/en\/ip_20_2200\">Moderna<\/a>\u00a0and the concluded exploratory talks with\u00a0<a href=\"https:\/\/ec.europa.eu\/commission\/presscorner\/detail\/en\/ip_21_51\">Valneva<\/a>. It represents another key step towards ensuring that Europe is well prepared to face the COVID-19 pandemic.<\/p>\n<h3>Novavax<\/h3>\n<p>Novavax is a biotechnology company developing next-generation vaccines for serious infectious diseases. Their COVID-19 vaccine is already under rolling review by EMA in view of a potential market authorisation.<\/p>\n<p>The Commission has taken a decision to support this vaccine based on a sound scientific assessment, the technology used, the company&#8217;s experience in vaccine development and its production capacity to supply the whole of the EU.<\/p>\n<h3>More information<\/h3>\n<p><a href=\"https:\/\/ec.europa.eu\/commission\/presscorner\/detail\/en\/ip_21_4061\">European Commission &#8211; Press release<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The European Commission has approved its seventh Advanced Purchase Agreement (APA) with a pharmaceutical company to ensure access to a potential vaccine against COVID-19 in Q4 of 2021 and in 2022. Under this contract, Member States will be able to purchase up to 100 million doses of the Novavax vaccine, with an option for 100 [&hellip;]<\/p>\n","protected":false},"author":101011,"featured_media":61132,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","footnotes":""},"categories":[346,4092,4082],"tags":[1352,2366,368,351],"class_list":{"0":"post-77829","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-eu-news","8":"category-health","9":"category-research-innovation","10":"tag-covid-19","11":"tag-covid-19-2-en","12":"tag-european-union","13":"tag-union-europea-en","14":"entry"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Commission approves new contract for a potential COVID-19 vaccine with Novavax | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cde.ual.es\/en\/commission-approves-new-contract-for-a-potential-covid-19-vaccine-with-novavax\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Commission approves new contract for a potential COVID-19 vaccine with Novavax | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda\" \/>\n<meta property=\"og:description\" content=\"The European Commission has approved its seventh Advanced Purchase Agreement (APA) with a pharmaceutical company to ensure access to a potential vaccine against COVID-19 in Q4 of 2021 and in 2022. Under this contract, Member States will be able to purchase up to 100 million doses of the Novavax vaccine, with an option for 100 [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cde.ual.es\/en\/commission-approves-new-contract-for-a-potential-covid-19-vaccine-with-novavax\/\" \/>\n<meta property=\"og:site_name\" content=\"CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/cdeuniversidadalmeria\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-06T01:00:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2021\/02\/vacuna-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1706\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"BECA 2 CDE\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@cdeualmeria\" \/>\n<meta name=\"twitter:site\" content=\"@cdeualmeria\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"BECA 2 CDE\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-approves-new-contract-for-a-potential-covid-19-vaccine-with-novavax\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-approves-new-contract-for-a-potential-covid-19-vaccine-with-novavax\\\/\"},\"author\":{\"name\":\"BECA 2 CDE\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#\\\/schema\\\/person\\\/ee46ebc19edfa19598c02cff83335acc\"},\"headline\":\"Commission approves new contract for a potential COVID-19 vaccine with Novavax\",\"datePublished\":\"2021-08-06T01:00:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-approves-new-contract-for-a-potential-covid-19-vaccine-with-novavax\\\/\"},\"wordCount\":226,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-approves-new-contract-for-a-potential-covid-19-vaccine-with-novavax\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2021\\\/02\\\/vacuna-scaled.jpg\",\"keywords\":[\"covid-19\",\"covid-19\",\"European Union\",\"Uni\u00f3n Europea\"],\"articleSection\":[\"EU News\",\"Health\",\"Research and Innovation\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-approves-new-contract-for-a-potential-covid-19-vaccine-with-novavax\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-approves-new-contract-for-a-potential-covid-19-vaccine-with-novavax\\\/\",\"url\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-approves-new-contract-for-a-potential-covid-19-vaccine-with-novavax\\\/\",\"name\":\"Commission approves new contract for a potential COVID-19 vaccine with Novavax | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-approves-new-contract-for-a-potential-covid-19-vaccine-with-novavax\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-approves-new-contract-for-a-potential-covid-19-vaccine-with-novavax\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2021\\\/02\\\/vacuna-scaled.jpg\",\"datePublished\":\"2021-08-06T01:00:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-approves-new-contract-for-a-potential-covid-19-vaccine-with-novavax\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-approves-new-contract-for-a-potential-covid-19-vaccine-with-novavax\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-approves-new-contract-for-a-potential-covid-19-vaccine-with-novavax\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2021\\\/02\\\/vacuna-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2021\\\/02\\\/vacuna-scaled.jpg\",\"width\":2560,\"height\":1706},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-approves-new-contract-for-a-potential-covid-19-vaccine-with-novavax\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EU News\",\"item\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/category\\\/eu-news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Health\",\"item\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/category\\\/eu-news\\\/health\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Commission approves new contract for a potential COVID-19 vaccine with Novavax\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#website\",\"url\":\"https:\\\/\\\/www.cde.ual.es\\\/\",\"name\":\"CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda\",\"description\":\"Centro de Documentaci\u00f3n Europea de la Universidad de Almer\u00eda\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#organization\"},\"alternateName\":\"CDE Almer\u00eda\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cde.ual.es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#organization\",\"name\":\"Centro de Documentaci\u00f3n Europea de Almer\u00eda\",\"url\":\"https:\\\/\\\/www.cde.ual.es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/cde-logo-3.png\",\"contentUrl\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/cde-logo-3.png\",\"width\":1400,\"height\":300,\"caption\":\"Centro de Documentaci\u00f3n Europea de Almer\u00eda\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/cdeuniversidadalmeria\\\/\",\"https:\\\/\\\/x.com\\\/cdeualmeria\",\"https:\\\/\\\/www.tiktok.com\\\/@cdealmeria\",\"https:\\\/\\\/www.instagram.com\\\/cdealmeria\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/cde-almera-812b26a9\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#\\\/schema\\\/person\\\/ee46ebc19edfa19598c02cff83335acc\",\"name\":\"BECA 2 CDE\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/35a481bbc04bbd90e91bdfa3b0b5541036c222a49b9ad37b6889a2afcb5311a5?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/35a481bbc04bbd90e91bdfa3b0b5541036c222a49b9ad37b6889a2afcb5311a5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/35a481bbc04bbd90e91bdfa3b0b5541036c222a49b9ad37b6889a2afcb5311a5?s=96&d=mm&r=g\",\"caption\":\"BECA 2 CDE\"},\"sameAs\":[\"http:\\\/\\\/www.cdealmeria.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Commission approves new contract for a potential COVID-19 vaccine with Novavax | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cde.ual.es\/en\/commission-approves-new-contract-for-a-potential-covid-19-vaccine-with-novavax\/","og_locale":"en_US","og_type":"article","og_title":"Commission approves new contract for a potential COVID-19 vaccine with Novavax | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda","og_description":"The European Commission has approved its seventh Advanced Purchase Agreement (APA) with a pharmaceutical company to ensure access to a potential vaccine against COVID-19 in Q4 of 2021 and in 2022. Under this contract, Member States will be able to purchase up to 100 million doses of the Novavax vaccine, with an option for 100 [&hellip;]","og_url":"https:\/\/www.cde.ual.es\/en\/commission-approves-new-contract-for-a-potential-covid-19-vaccine-with-novavax\/","og_site_name":"CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda","article_publisher":"https:\/\/www.facebook.com\/cdeuniversidadalmeria\/","article_published_time":"2021-08-06T01:00:12+00:00","og_image":[{"width":2560,"height":1706,"url":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2021\/02\/vacuna-scaled.jpg","type":"image\/jpeg"}],"author":"BECA 2 CDE","twitter_card":"summary_large_image","twitter_creator":"@cdeualmeria","twitter_site":"@cdeualmeria","twitter_misc":{"Written by":"BECA 2 CDE","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cde.ual.es\/en\/commission-approves-new-contract-for-a-potential-covid-19-vaccine-with-novavax\/#article","isPartOf":{"@id":"https:\/\/www.cde.ual.es\/en\/commission-approves-new-contract-for-a-potential-covid-19-vaccine-with-novavax\/"},"author":{"name":"BECA 2 CDE","@id":"https:\/\/www.cde.ual.es\/#\/schema\/person\/ee46ebc19edfa19598c02cff83335acc"},"headline":"Commission approves new contract for a potential COVID-19 vaccine with Novavax","datePublished":"2021-08-06T01:00:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cde.ual.es\/en\/commission-approves-new-contract-for-a-potential-covid-19-vaccine-with-novavax\/"},"wordCount":226,"commentCount":0,"publisher":{"@id":"https:\/\/www.cde.ual.es\/#organization"},"image":{"@id":"https:\/\/www.cde.ual.es\/en\/commission-approves-new-contract-for-a-potential-covid-19-vaccine-with-novavax\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2021\/02\/vacuna-scaled.jpg","keywords":["covid-19","covid-19","European Union","Uni\u00f3n Europea"],"articleSection":["EU News","Health","Research and Innovation"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.cde.ual.es\/en\/commission-approves-new-contract-for-a-potential-covid-19-vaccine-with-novavax\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.cde.ual.es\/en\/commission-approves-new-contract-for-a-potential-covid-19-vaccine-with-novavax\/","url":"https:\/\/www.cde.ual.es\/en\/commission-approves-new-contract-for-a-potential-covid-19-vaccine-with-novavax\/","name":"Commission approves new contract for a potential COVID-19 vaccine with Novavax | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda","isPartOf":{"@id":"https:\/\/www.cde.ual.es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cde.ual.es\/en\/commission-approves-new-contract-for-a-potential-covid-19-vaccine-with-novavax\/#primaryimage"},"image":{"@id":"https:\/\/www.cde.ual.es\/en\/commission-approves-new-contract-for-a-potential-covid-19-vaccine-with-novavax\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2021\/02\/vacuna-scaled.jpg","datePublished":"2021-08-06T01:00:12+00:00","breadcrumb":{"@id":"https:\/\/www.cde.ual.es\/en\/commission-approves-new-contract-for-a-potential-covid-19-vaccine-with-novavax\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cde.ual.es\/en\/commission-approves-new-contract-for-a-potential-covid-19-vaccine-with-novavax\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.cde.ual.es\/en\/commission-approves-new-contract-for-a-potential-covid-19-vaccine-with-novavax\/#primaryimage","url":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2021\/02\/vacuna-scaled.jpg","contentUrl":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2021\/02\/vacuna-scaled.jpg","width":2560,"height":1706},{"@type":"BreadcrumbList","@id":"https:\/\/www.cde.ual.es\/en\/commission-approves-new-contract-for-a-potential-covid-19-vaccine-with-novavax\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/www.cde.ual.es\/en\/"},{"@type":"ListItem","position":2,"name":"EU News","item":"https:\/\/www.cde.ual.es\/en\/category\/eu-news\/"},{"@type":"ListItem","position":3,"name":"Health","item":"https:\/\/www.cde.ual.es\/en\/category\/eu-news\/health\/"},{"@type":"ListItem","position":4,"name":"Commission approves new contract for a potential COVID-19 vaccine with Novavax"}]},{"@type":"WebSite","@id":"https:\/\/www.cde.ual.es\/#website","url":"https:\/\/www.cde.ual.es\/","name":"CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda","description":"Centro de Documentaci\u00f3n Europea de la Universidad de Almer\u00eda","publisher":{"@id":"https:\/\/www.cde.ual.es\/#organization"},"alternateName":"CDE Almer\u00eda","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cde.ual.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.cde.ual.es\/#organization","name":"Centro de Documentaci\u00f3n Europea de Almer\u00eda","url":"https:\/\/www.cde.ual.es\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.cde.ual.es\/#\/schema\/logo\/image\/","url":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2025\/07\/cde-logo-3.png","contentUrl":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2025\/07\/cde-logo-3.png","width":1400,"height":300,"caption":"Centro de Documentaci\u00f3n Europea de Almer\u00eda"},"image":{"@id":"https:\/\/www.cde.ual.es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/cdeuniversidadalmeria\/","https:\/\/x.com\/cdeualmeria","https:\/\/www.tiktok.com\/@cdealmeria","https:\/\/www.instagram.com\/cdealmeria\/","https:\/\/www.linkedin.com\/in\/cde-almera-812b26a9\/"]},{"@type":"Person","@id":"https:\/\/www.cde.ual.es\/#\/schema\/person\/ee46ebc19edfa19598c02cff83335acc","name":"BECA 2 CDE","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/35a481bbc04bbd90e91bdfa3b0b5541036c222a49b9ad37b6889a2afcb5311a5?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/35a481bbc04bbd90e91bdfa3b0b5541036c222a49b9ad37b6889a2afcb5311a5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/35a481bbc04bbd90e91bdfa3b0b5541036c222a49b9ad37b6889a2afcb5311a5?s=96&d=mm&r=g","caption":"BECA 2 CDE"},"sameAs":["http:\/\/www.cdealmeria.com"]}]}},"_links":{"self":[{"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/posts\/77829","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/users\/101011"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/comments?post=77829"}],"version-history":[{"count":0,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/posts\/77829\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/media\/61132"}],"wp:attachment":[{"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/media?parent=77829"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/categories?post=77829"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/tags?post=77829"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}